Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure solutions remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/pu-prime-wins-best-multi-asset-broker-mea-2025-at-ifx-expo-dubai/